E2F7 plays an indispensable role in a variety of tumors, such as gallbladder cancer (27), rectal adenocarcinoma (28), and breast cancer (29), indicating that E2F7 may be a potential prognostic marker. This evidence concerns the gene E2F7 and rectum adenocarcinoma.